• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - OMRF News - Archives for dpas

dpas

OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases

July 24, 2017

This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.

Filed Under: News, Technology Ventures News Tagged With: acute pancreatitis, agreement, blood, business, Charles, charles esmon, chuck esmon, collaboration, company, death, discovery partnerships with academia, dpas, drug, Esmon, Florea, Florea Lupu, gsk, healthcare, histones, lung injury, Lupu, newsok, nonprofit, novel, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, organ damage, padmaja mehta-D-souza, partner, research, scientist-news, scientists, therapy, toxic, trauma

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace